Alkermes Announces the Appointment of Richard Gaynor, M.D. and Andy Wilson to its Board of Directors and the Retirement of Director Floyd Bloom, M.D.
DUBLIN,Sept. 13, 2019/PRNewswire/ --Alkermes plc(Nasdaq: ALKS) today announced the appointment of two new independent directors,Richard Gaynor, M.D. andFrank Anders (Andy) Wilson, to the company's Board of Directors. The company also announced the retirement ofFloyd Bloom, M.D., a pioneer in the field of neuroscience who contributed immensely to the legacy of innovation and scientific excellence that remains core to Alkermes' mission today...Read Full Article